Skip to main content
NCBI home page
Journal of Assisted Reproduction and Genetics logoLink to Journal of Assisted Reproduction and Genetics
. 1997 Oct;14(9):518–524. doi: 10.1023/A:1021127410300

Endogenous LH Surge Versus hCG as Ovulation Trigger After Low-Dose Highly Purified FSH in IUI: A Comparison of 761 Cycles

A Romeu 1,✉, A Monzó 1, T Peiró 1, E Diez 1, J A Peinado 2, L A Quintero 1
PMCID: PMC3454846  PMID: 9401870

Abstract

Purpose: The results obtained with a protocol consisting of ovarian stimulation with low doses of highly purified FSH (FSH HP), administration of a GnRH analogue to induce an endogenous surge of gonadotropins, and IUI were evaluated. These results were compared with those seen with similar FSH stimulation and hCG administration followed by IUI.

Methods: Three hundred sixty-four patients scheduled for IUI, after inclusion in a total of 345 FSH HP/GnRH-stimulated cycles and 416 FSH HP/HCG-stimulated cycles, were studied. The stimulation protocol consisted of daily subcutaneous injection of 75 IU of FSH HP from day 3 or 5 of the cycle, depending on the duration of the spontaneous cycle. hCG was administered on days 0, +2, and +5 to support the luteal phase. Monitoring was conducted using circulating estradiol levels and vaginal ultrasonography. Administration of two s.c. doses of leuprolide acetate (LA) or 7500 IU of i.m. hCG when at least one 18-mm-diameter follicle was seen and estradiol levels reached 120 pg/ml per follicle with a diameter ≥16 mm. Intrauterine insemination was with semen capacitated by swim-up, thawed at room temperature if previously frozen.

Results: The ovulation rate was 99.28 after hCG and 99.23 with LA. No significant differences were seen between the estradiol and progesterone levels of both groups or in the estradiol/progesterone ratio. The duration of the luteal phase was similar in both groups. Pregnancy rates per cycle were 17.31% (hCG) and 27.25% (LA), respectively (P = 0.0007), and abortion rates 22.22% (hCG) and 24.47% (LA), respectively. No cases of ovarian hyperstimulation were seen.

Conclusions: After FSH HP administration according to a low-dose protocol, the use of LA to trigger a gonadotropin surge as a means of inducing ovulation in FSH-stimulated women could be a good alternative to improve the results and prevent ovarian hyperstimulation in IUI cycles.

Keywords: ovulation, highly purified follicle stimulating hormone, human chorionic gonadotropin, leuprolide acetate, intrauterine insemination

Full Text

The Full Text of this article is available as a PDF (633.3 KB).

REFERENCES

  • 1.Schenker J, Weinstein D. Ovarian hyperstimulation syndrome: A current survey. Fertil Steril. 1978;30:255–268. doi: 10.1016/s0015-0282(16)43508-9. [DOI] [PubMed] [Google Scholar]
  • 2.Navot D, Rebou A, Birkenfeld A. Risk factors and prognostic variables in the ovarian hyperstimulation syndrome. Am J Obstet Gynecol. 1988;159:210–216. doi: 10.1016/0002-9378(88)90523-6. [DOI] [PubMed] [Google Scholar]
  • 3.Homburg R, Levy T, Ben-Rafael Z. A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for anovulation associated with policystic ovary syndrome. Fertil Steril. 1995;63:729–733. doi: 10.1016/s0015-0282(16)57473-1. [DOI] [PubMed] [Google Scholar]
  • 4.Balasch J, Ballesca JL, Pimentel C, Creus M, Fabregues F, Vanrell JA. Late low-dose pure follicle stimulating hormone for ovarian stimulation in intra-uterine insemination cycles. Hum Reprod. 1994;9:1863–1866. doi: 10.1093/oxfordjournals.humrep.a138349. [DOI] [PubMed] [Google Scholar]
  • 5.Balasch J, Tur R, Peinado JA. The safety and effectiveness of stepwise and low-dose administration of follicle stimulating hormone in WHO group II anovulatory infertile women: Evidence from a large multicenter study in Spain. J Assist Reprod Genet. 1996;13:551–556. doi: 10.1007/BF02066607. [DOI] [PubMed] [Google Scholar]
  • 6.Catt J, Dufau M. Gonadotropic hormones: Biosynthesis, secretion, receptors and actions. In: Yen S, Jaffe R, editors. Reproductive Endocrinology. Philadelphia: W. B. Saunders; 1991. pp. 105–155. [Google Scholar]
  • 7.Conbarnous Y. Comparative approach of structure function relationships of gonadotropins. Serono Symp. 1989;65:82–93. [Google Scholar]
  • 8.Molina I, Pla M, Vicente J, Martin A, Romeu A. Induction of ovulation in rabbits with pure urinary luteinizing hormone and human chorionic gonadotropin: Comparison of oocyte and embryo quality. Hum Reprod. 1991;6:1449–1452. doi: 10.1093/oxfordjournals.humrep.a137287. [DOI] [PubMed] [Google Scholar]
  • 9.Peinado J, Molina 1, Pia M, Tresguerres J, Romeu A: Recombinant-human luteinizing hormone (r-hLH) as ovulatory stimulus in superovulated does. J Assist Reprod Genet. 1995;12(1):61–64. doi: 10.1007/BF02214131. [DOI] [PubMed] [Google Scholar]
  • 10.Romeu A, Molina I, Tresguerres J, Pla M, Peinado J. Effect of recombinant human luteinizing hormone versus human chrorionic gonadotropin: Effects on ovulation, embryo quality and transport, steroid balance and implantation in rabbits. Hum Reprod. 1995;10(5):1290–1296. doi: 10.1093/oxfordjournals.humrep.a136136. [DOI] [PubMed] [Google Scholar]
  • 11.Corson S, Batzer F, Gocial B, Maislin G. The luteal phase after ovulation induction with human menopausal gonadotropin and one versus two doses of a gonadotropin releasing hormone agonist. Fertil Steril. 1993;59:1251–1256. doi: 10.1016/s0015-0282(16)55985-8. [DOI] [PubMed] [Google Scholar]
  • 12.Romeu A, Monzó A, Martin-Cortés A, Rodriguez-Ineba A, González-Santana A. Desencadenamlento de la ovulación con un análogo agonista de LHRH en ciclos estimulados con FSH pura: Nueva indicación en la Enfermedad Poliquistica del Ovario (EPO)? Revista Iberoam Fert. 1993;10:329–333. [Google Scholar]
  • 13.Tukchinsky D, Nash H, Brown K, Paoletti-Falcone V, Poicaro J. A pilot study of the use of gonadotropin releasing hormone analog for triggering ovulation. Fertil Steril. 1991;55:644–646. doi: 10.1016/s0015-0282(16)54204-6. [DOI] [PubMed] [Google Scholar]
  • 14.Gonen Y, Balakier H, Powell W, Casper R. Use of gonabotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization. J Clin Endocrinol Metab. 1990;71:918–922. doi: 10.1210/jcem-71-4-918. [DOI] [PubMed] [Google Scholar]
  • 15.Imoedemhe D, Sigue A, Pacpaco E, Olazo A. Stimulation of endogenous surge of luteinizing hormone with gonadotropin-releasing hormone analog after ovarian stimulation of in vitro fertilization. Fertil Steril. 1991;55:328–332. doi: 10.1016/s0015-0282(16)54125-9. [DOI] [PubMed] [Google Scholar]
  • 16.Itskovitz J, Boldes R, Levron J, Erlik Y, Kahana L, Grandes J. Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertil Steril. 1991;56:213–220. [PubMed] [Google Scholar]
  • 17.Eppig J. FSH stimulates hyaluronic acid synthesis by oocyte-cumulus complexes from mouse preovulatory follicle. Nature. 1979;281:483–486. doi: 10.1038/281483a0. [DOI] [PubMed] [Google Scholar]
  • 18.Stickland S, Beers W. Studies on the role of plasminogen activator in ovulation. In vitro response of granulosa cells to gonadotropins, cyclic nucleotides and prostaglandins. J Biol Chem. 1976;251:5694–5699. [PubMed] [Google Scholar]
  • 19.Yen SSC. The human menstrual cycle: Neuroendocrine regulation. In: Yen SSC, Jaffe RB, editors. Reproductive Endocrinology. Philadelphia: W. B. Saunders; 1991. pp. 273–308. [Google Scholar]
  • 20.Nillius SJ, Wide L. Variation of oestrogens on serum levels of LH and FSH. Acta Endocr Kbh. 1970;65:583–594. doi: 10.1530/acta.0.0650583. [DOI] [PubMed] [Google Scholar]
  • 21.Nillius SJ, Wide L. Variation in LH and FSH response to LH releasing hormone during the menstrual cycle. J Obstet Gynaecol Br Cwlth. 1971;79:862–873. doi: 10.1111/j.1471-0528.1972.tb12182.x. [DOI] [PubMed] [Google Scholar]
  • 22.Cavagna M, Soares J, Freitas G, et al. Use of gonadotropin-releasing hormone agonist to induce preovulatory gonadotropins surge and trigger follicular maturation. Contracept Fertil Sex. 1995;23:S17. [Google Scholar]
  • 23.Gerris J, De Vits A, Devree B, Joostens M. Triggering of ovulation in HMG-stimulated cycles: comparison between i.v. administered GNRH (100 and 500 pg), GnRH-agonist (Buserelin, 500 pg) and hCG (1 0000 IU) Contracept Fertil Sex. 1995;23:S17. doi: 10.1093/humrep/10.1.56. [DOI] [PubMed] [Google Scholar]
  • 24.Olivennes F, Franchin R, Bouchard P, Taieb J, Frydman R: Triggering of ovulation with GNRH agonist in patients treated with a GNRH antagonist during the stimulation cycle. Contracept Fertil Sex. 1995;23:S18. [Google Scholar]

Articles from Journal of Assisted Reproduction and Genetics are provided here courtesy of Springer Science+Business Media, LLC

RESOURCES